Related Experiment Video

Updated: Sep 28, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.8K

How should randomized controlled trials in epithelial ovarian cancer be interpreted?

Inge Peters1, Andrea Rosati1, Giovanni Scambia1

  • 1Department of Woman's and Child Health and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|April 1, 2022
PubMed
Summary

No abstract available in PubMed .

Keywords:
Ovarian Cancer

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K

Related Experiment Videos

Last Updated: Sep 28, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.8K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

186
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186
Randomized Experiments01:13

Randomized Experiments

8.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.0K

Articles linked to this work by shared authors, journal, and citation graph.

p16(INK4a) immunohistochemical expression is a strong predictor of treatment response and survival in patients with locally advanced squamous cell vulvar cancer undergoing upfront chemoradiotherapy.

Journal of gynecologic oncology·2026

The Impact of Thyroid Autoimmunity, Glucose Metabolism, and Vitamin D Status in Women With Recurrent Pregnancy Loss: A Retrospective Study.

Endocrine, metabolic & immune disorders drug targets·2026

Toumai robotic system in uterine cancer surgery: first report of sentinel lymph node dissection in ten steps.

Facts, views & vision in ObGyn·2026

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer.

International journal of molecular sciences·2026

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Controlled Ovarian Stimulation After Fertility-Sparing Surgery for Borderline Ovarian Tumors: An Exploratory Cohort Study on Recurrence and Reproductive Outcomes.

Current oncology (Toronto, Ont.)·2026

Clinical and pathological outcomes of brachytherapy application for the treatment of high-grade vaginal squamous intraepithelial lesions: a systematic review.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Surgical management and outcomes in localized vulvar basal cell carcinoma: a National Cancer Database Study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Marital status and its association with vulvar melanoma outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Gynecologic Cancer InterGroup code of conduct for diversity in gynecological cancer trials: a clinical guide from the Berlin Gynecologic Cancer InterGroup meeting.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Genes & diseases·2026

Candida Albicans Purulent Pericarditis Complicated by Cardiac Tamponade in a Critically Ill Burn Patient: A Case Report.

Journal of the Saudi Heart Association·2026

Advances in quinazolin-4-one scaffolds in breast cancer therapy: emerging designs, mechanistic perspectives and SAR trends (2015-2025).

RSC medicinal chemistry·2026

Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation.

Frontiers in oncology·2026

BUB1 regulates cell proliferation and apoptosis in cervical cancer by AKT signaling and autophagosome-lysosome fusion via ACTN1.

iScience·2026

Human relevant platforms for cutaneous wound healing research: current landscape, translational gaps, and emerging frontiers.

Frontiers in bioengineering and biotechnology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us